Pharmaust Limited (AU:NUZ) has released an update. Neurizon Therapeutics Limited has reported promising preclinical results for its lead drug ...
Pharmaust Limited (AU:NUZ) has released an update. Neurizon Therapeutics has announced promising preclinical results for its lead drug ...
After a comprehensive two-year follow-up, researchers found that MRI-guided stereotactic body radiotherapy (SBRT) for prostate cancer significantly reduced long-term side effects and improved quality ...
From advanced imaging to AI-driven analysis, we seek studies that not only push the boundaries of what is possible but also directly address the clinical needs of conditions such as ALS, Autism ...
After a comprehensive two-year follow-up, researchers at the UCLA Health Jonsson Comprehensive Cancer Center found that ...